alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 21
 Subsidiaries of Registrant
 Date and % of VotingShares, PartnershipInterests, Voting TrustYear &
    
    Certificates, CapitalName & Address
    
    State Inc.
    
    Contributions
    
    Description of ActivityHome Federal Savings Bank
    
    1934
    
    6/29/94
    
    Federally Chartered Stock1016 Civic Center Drive NW
    
    Federal
    
    HMN owns 100% of
    
    Savings BankRochester, MN 55901
    
    Charter
    
    voting sharesOsterud Insurance Agency, Inc.
    
    1983
    
    12/1983
    
    Investment products andDBA Home Federal Investment Svcs.
    
    MN
    
    Bank owns 100%
    
    financial planning1016 Civic Center Drive NW 

Rochester, MN 55901Security Finance Corporation
    
    1929
    
    12/29/95
    
    Corporation invests in1016 Civic Center Drive NW
    
    MN
    
    HMN owns 100% of
    
    Securities, loans and real estateRochester, MN 55901
    
    
    
    voting shares
IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA

 

IN RE: BARD IVC FILTERS PRODUCTS No. MDL15-02641-PHX DGC 

LIABILITY LITIGATION 

 

 ORDER 

This document is related to Plaintiff(s) 

LAKEYA BASKOM

No. CV17-02427-PHX DGC

Considering the Stipulation of Dismissal Without Prejudice of Lakeya Baskom. 

Doc. 9226.

IT IS HEREBY ORDERED, ADJUDGED AND DECLARED that the 

stipulation of dismissal without prejudice of Lakeya Baskom (Doc. 9226) is granted. All 

claims of Plaintiff, Lakeya Baskom against Defendants C.R. Bard, Inc. and Bard 

Peripheral Vascular, Inc., in Civil Action No. MDL No. 2641 (Member Case CV17-02427 

PHX DGC) are dismissed in their entirety without prejudice as to the refiling of same, and 

each party shall bear its own costs. 

Dated this 6th day of December, 2017. 

Case 2:15-md-02641-DGC Document 9241 Filed 12/07/17 Page 1 of 1
[Federal Register Volume 79, Number 200 (Thursday, October 16, 2014)]
[Notices]
[Pages 62207-62208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-24594]


=======================================================================
-----------------------------------------------------------------------

NATIONAL FOUNDATION ON THE ARTS AND THE HUMANITIES


Meetings of Humanities Panel; Correction

AGENCY: National Endowment for the Humanities.

ACTION: Notice of Meetings; correction.

-----------------------------------------------------------------------

SUMMARY: The National Endowment for the Humanities published a document 
in the Federal Register of September 15, 2014, concerning notice of 
meetings of the Humanities Panel during the month of October 2014. 
Three meetings were added to the schedule after the notice was posted. 
All other information remains the same.

FOR FURTHER INFORMATION CONTACT: Lisette Voyatzis, (202) 606-8322.

Correction

    In the Federal Register of September 15, 2014, in FR Doc. 2014-
21962, on page 55018, in the third column, replace the ``Summary'' 
caption with:

SUMMARY: The National Endowment for the Humanities will hold seventeen 
meetings of the Humanities Panel, a federal advisory committee, during 
October, 2014. The purpose of the meetings is for panel review, 
discussion, evaluation, and recommendation of applications for 
financial assistance under the National Foundation on the Arts and 
Humanities Act of 1965.
    In the Federal Register of September 15, 2014, in FR Doc. 2014-
21962, on

[[Page 62208]]

page 55019, in the second column after line thirty-seven (37) add:

15. DATE: October 28, 2014
TIME: 8:30 a.m. to 5:00 p.m.
ROOM: Conference Call

    This meeting will discuss applications for the Enduring Questions: 
Pilot Course Grants program, submitted to the Division of Education 
Programs.

16. DATE: October 29, 2014
TIME: 8:30 a.m. to 5:00 p.m.
ROOM: Conference Call

    This meeting will discuss applications for the Enduring Questions: 
Pilot Course Grants program, submitted to the Division of Education 
Programs.
17. DATE: October 30, 2014
TIME: 8:30 a.m. to 5:00 p.m.
ROOM: Conference Call

    This meeting will discuss applications for the Enduring Questions: 
Pilot Course Grants program, submitted to the Division of Education 
Programs.

    Dated: October 10, 2014.
Lisette Voyatzis,
Committee Management Officer.
[FR Doc. 2014-24594 Filed 10-15-14; 8:45 am]
BILLING CODE 7536-01-P
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

Sandra T. Mock,

Plaintiff,

v.

C. R. Bard Inc. and Bard Peripheral 

Vascular, Inc.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-17-04115-PHX-DGC

WAIVER OF THE SERVICE OF SUMMONS

To: Osborne & Associates Law Firm, PA

(Name of plaintiff’s attorney or unrepresented plaintiff)

I have received your request to waive service of a summons in this action along with a copy of the complaint, two 

copies of this waiver form, and a prepaid means of returning one signed copy of the form to you.

I, or the entity I represent, agree to save the expense of serving a summons and complaint in this case.

I understand that I, or the entity I represent, will keep all defenses or objections to the lawsuit, the court’s 

jurisdiction, and the venue of the action, but that I waive any objections to the absence of a summons or of service.

I also understand that I, or the entity I represent, must file and serve an answer or a motion under Rule 12 within 

60 days from 11/9/2017, the date when this request was sent (or 90 days if it was sent outside the United States). If I fail 

to do so, a default judgment will be entered against me or the entity I represent.

Date: November 27, 2017 /s/ Richard B. North, Jr.

Signature of the attorney or unrepresented party

C. R. Bard, Inc. and Bard Peripheral

Vascular, Inc.

Printed name of parties waiving service of 

summons

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed Name

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6155

Telephone number

Duty to Avoid Unnecessary Expenses of Serving a Summons

Rule 4 of the Federal Rules of Civil Procedure requires certain defendants to cooperate in saving unnecessary expenses of serving a 

summons and complaint. A defendant who is located in the United States and who fails to return a signed waiver of service requested by a plaintiff 

located in the United States will be required to pay the expenses of service, unless the defendant shows good cause for the failure. 

“Good cause” does not include a belief that the lawsuit is groundless, or that it has been brought in an improper venue, or that the court has 

no jurisdiction over this matter or over the defendant or the defendant’s property. 

If the waiver is signed and returned, you can still make these and all other defenses and objections, but you cannot object to the absence of 

a summons or of service. 

If you waive service, then you must, within the time specified on the waiver form, serve an answer or a motion under Rule 12 on the 

plaintiff and file a copy with the court. By signing and returning the waiver form, you are allowed more time to respond than if a summons had been 

served.

Case 2:15-md-02641-DGC Document 9004 Filed 11/30/17 Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000894245
<NAME> AEI NET LEASE INCOME & GROWTH FUND XX LIMITED PARTNERSHIP
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                       2,800,543
<SECURITIES>                                         0
<RECEIVABLES>                                   11,150
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,811,693
<PP&E>                                      17,256,847
<DEPRECIATION>                             (1,042,102)
<TOTAL-ASSETS>                              19,026,438
<CURRENT-LIABILITIES>                          546,242
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  18,480,196
<TOTAL-LIABILITY-AND-EQUITY>                19,026,438
<SALES>                                              0
<TOTAL-REVENUES>                               509,177
<CGS>                                                0
<TOTAL-COSTS>                                  196,829
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                446,512
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            446,512
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   446,512
<EPS-PRIMARY>                                    18.90
<EPS-DILUTED>                                    18.90
        

</TABLE>
**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation byreference in the Registration Statements (Form S-8 Nos. 333-121328, 333-19389, 333-44717, 333-98195, 333-100266, 333-68984, 333-64230, 333-60358, 333-54526, 333-49026, 333-43560, 333-109333 and 333-128264) pertaining to the 1992 Stock Option Plan,the 1994 Equity Incentive Plan, the Non-Employee Directors’ Stock Option Plan, the 2000 Nonstatutory Incentive Plan, the 2000 Equity Incentive Plan, the 2004 Employment Commencement Incentive Plan and the Employee Stock Purchase Plan of CVTherapeutics, Inc., and the Registration Statements (Form S-3 Nos. 333-38528, 333-53202, 333-59318, 333-109427, 333-109428, 333-118805 and 333-126204) and in the related Prospectuses of our reports dated February 24, 2006, with respect to theconsolidated financial statements of CV Therapeutics, Inc., CV Therapeutics Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of CVTherapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2005. 

/s/    Ernst & Young, LLP 

Palo Alto, California 

March 8, 2006
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"Robert E. Lewis","author_url":"https:\/\/www.nasa.gov\/author\/robert-e-lewisnasa-gov\/","title":"Neuroscience","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"xQQtICKghb\"><a href=\"https:\/\/www.nasa.gov\/directorates\/esdmd\/hhp\/neuroscience\/\">Neuroscience<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/directorates\/esdmd\/hhp\/neuroscience\/embed\/#?secret=xQQtICKghb\" width=\"600\" height=\"338\" title=\"“Neuroscience” — NASA\" data-secret=\"xQQtICKghb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.nasa.gov\/wp-content\/uploads\/2023\/03\/hhp-neuroscience-helicopter.jpeg?w=600","thumbnail_width":600,"thumbnail_height":388}
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-START>                             AUG-01-1999
<PERIOD-END>                               JUL-31-2000
<CASH>                                          14,066
<SECURITIES>                                         0
<RECEIVABLES>                                   13,833
<ALLOWANCES>                                       421
<INVENTORY>                                      8,926
<CURRENT-ASSETS>                                39,098
<PP&E>                                           5,074
<DEPRECIATION>                                   4,813
<TOTAL-ASSETS>                                  43,217
<CURRENT-LIABILITIES>                           11,906
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             9
<OTHER-SE>                                      30,360
<TOTAL-LIABILITY-AND-EQUITY>                    43,217
<SALES>                                         55,201
<TOTAL-REVENUES>                                55,201
<CGS>                                           42,891
<TOTAL-COSTS>                                   42,891
<OTHER-EXPENSES>                                12,163
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  32
<INCOME-PRETAX>                                (1,983)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,983)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,983)
<EPS-BASIC>                                      (.39)
<EPS-DILUTED>                                    (.39)


</TABLE>
OFFICE OF 

tfN1lA.t 

COUNSEL 

tlrrtui COVNYL 

DBunASSOCIAIl ADYINISIRAIOR IPLANNINO) OFFICE OF 

ASSIIIANI AD~IHI~ltAlOt fO1 ?OtICV 

OFFICE OF 

SPACE SCIENCE 

AND APPLICATIONS 

APPIOVID 1 

ASSOCIATE 

DEPUTY 

ADMINISTRATOR 

TRACKING AND 

DATA ACQUISITION
EX-10.26





 Exhibit 10.26 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS
THE TYPE THAT THE HONEST COMPANY, INC. TREATS AS PRIVATE OR CONFIDENTIAL. 
 AMENDMENT SEVEN 

TO THE LOGISTICS SERVICES AGREEMENT 

This AMENDMENT SEVEN TO THE LOGISTICS SERVICES AGREEMENT (the “Amendment”) dated as of the 1st day of May, 2017 is by and between The Honest Company, Inc. (“Client”) and Geodis Logistics LLC (“GEODIS”). Client and GEODIS are collectively
referred to herein as the “Parties.” 
 RECITALS: 

A.    Client and GEODIS executed that certain Logistics Services Agreement dated January 31, 2014, and six
amendments thereto (collectively, the “Agreement”); and 
 B.    The Parties desire to
amend the Agreement as set forth herein. 
 NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, Client and GEODIS agree to amend the Agreement as follows: 
  

	 	1.	 Effective April 1, 2017, the attached Exhibit B—Revised Rialto, CA Rates shall replace all rates for
the services provided by GEODIS at the GEODIS Warehouse located at 1710 W. Baseline Road, Rialto, CA (“Rialto Warehouse”). [***] 


  

	 	2.	 The Parties agree that during the time period from [***], GEODIS accrued [***] in revenue for services rendered
on inbound cases at Rialto, however, these charges were not invoiced. The Parties agree that GEODIS will invoice the Client for the [***]. 


  

	 	3.	 Any capitalized terms not defined herein shall have the meanings set forth in the Agreement. Except as provided
herein, the Agreement shall remain unchanged and in full force and effect in accordance with its terms. It is specifically understood and agreed that the foregoing shall not be deemed to be a waiver or amendment of any other provision of the
Agreement or any of GEODIS’s rights or remedies under the Agreement. 


 IN WITNESS WHEREOF, the parties hereto have executed this
Amendment as of the date set forth above. 
  

			
	 The Honest Company, Inc.
	 	 Geodis Logistics LLC

		
	 Name: /s/ William
Ashton                                        
                    
	 	 Name: /s/ Mike
Honious                                        
                    

		
	 Title: SVP Operations
	 	 Title: COO

		
	 Date: 5/5/2017 14:26 PDT
	 	 Date: 5/5/17

		 	
		 	
		 	
		 	













 Exhibit B – Revised Rialto CA Rate 

Effective April 1, 2017 

[***]
UNITED STATES DISTRICT COURT 

FOR THE 

DISTRICT OF ARIZONA 

Anthony Jimenez, 

Plaintiff, 

v. 

Bard Peripheral Vascular, Inc. and C. R. 

Bard, Inc., et al., 

Defendant. 

) 

) 

) 

) 

) 

) 

) 

) 

) 

MDL Case No. 2:15-md-02641-DGC 

Civil Action No. CV-17-03981-PHX-DGC 

APPEARANCE OF COUNSEL 

To: The clerk of court and all parties of record 

I am admitted or otherwise authorized to practice in this court, and I appear in this case as counsel for: 

Defendants C. R. Bard, Inc. and Bard Peripheral Vascular, Inc. 

Date: November 6, 2017 /s/ Richard B. North, Jr. 

Attorney's signature 

Richard B. North, Jr. (Ga. Bar No. 545599) 

Printed name and bar number 

Nelson Mullins Riley & Scarborough, LLP 

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363 

Address 

richard.north@nelsonmullins.com 

E-mail Address 

(404) 322-6000 

Telephone number

(404 322-6050 

FAX number 

Case 2:15-md-02641-DGC Document 8608 Filed 11/06/17 Page 1 of 1
UNITED STATES DISTRICT COURT 

FOR THE 

DISTRICT OF ARIZONA 

Toni R. Ensey,

Plaintiff, 

v. 

C. R. Bard Inc., 

Defendant. 

)

) 

) 

) 

) 

) 

) 

) 

) 

MDL Case No. 2:15-md-02641-DGC 

Civil Action No. CV-17-04039-PHX-DGC 

WAIVER OF THE SERVICE OF SUMMONS 

To: Murphy Law Firm LLC 

(Name of plaintiff’s attorney or unrepresented plaintiff) 

I have received your request to waive service of a summons in this action along with a copy of the complaint, two 

copies of this waiver form, and a prepaid means of returning one signed copy of the form to you. 

I, or the entities I represent, agree to save the expense of serving a summons and complaint in this case. 

I understand that I, or the entities I represent, will keep all defenses or objections to the lawsuit, the court’s 

jurisdiction, and the venue of the action, but that I waive any objections to the absence of a summons or of service. 

I also understand that I, or the entity I represent, must file and serve an answer or a motion under Rule 12 within 

60 days from 11/02/2017, the date when this request was sent (or 90 days if it was sent outside the United States). If I fail 

to do so, a default judgment will be entered against me or the entities I represent. 

Date: November 10, 2017 /s/ Richard B. North, Jr.

Signature of the attorney or unrepresented party 

C. R. Bard, Inc. 

Printed name of party waiving service 

of summons 

Richard B. North, Jr. (Ga. Bar No. 545599) 

Printed Name 

Nelson Mullins Riley & Scarborough, LLP 

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363 

Address 

richard.north@nelsonmullins.com 

E-mail Address 

(404) 322-6155 

Telephone number 

 

Duty to Avoid Unnecessary Expenses of Serving a Summons

Rule 4 of the Federal Rules of Civil Procedure requires certain defendants to cooperate in saving unnecessary expenses of serving a 

summons and complaint. A defendant who is located in the United States and who fails to return a signed waiver of service requested by a plaintiff 

located in the United States will be required to pay the expenses of service, unless the defendant shows good cause for the failure. 

“Good cause” does not include a belief that the lawsuit is groundless, or that it has been brought in an improper venue, or that the court has 

no jurisdiction over this matter or over the defendant or the defendant’s property. 

If the waiver is signed and returned, you can still make these and all other defenses and objections, but you cannot object to the absence of 

a summons or of service. 

If you waive service, then you must, within the time specified on the waiver form, serve an answer or a motion under Rule 12 on the 

plaintiff and file a copy with the court. By signing and returning the waiver form, you are allowed more time to respond than if a summons had been 

served. 

Case 2:15-md-02641-DGC Document 8837 Filed 11/10/17 Page 1 of 1
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 2228 Introduced in Senate (IS)]

108th CONGRESS
  2d Session
                                S. 2228

   To authorize the issuance of a certificate of documentation with 
   appropriate endorsement for employment in the coastwise trade and 
                   fisheries for the vessel CROYANCE.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 23, 2004

   Mr. Allen introduced the following bill; which was read twice and 
   referred to the Committee on Commerce, Science, and Transportation

_______________________________________________________________________

                                 A BILL

 
   To authorize the issuance of a certificate of documentation with 
   appropriate endorsement for employment in the coastwise trade and 
                   fisheries for the vessel CROYANCE.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTIFICATE OF DOCUMENTATION FOR THE VESSEL CROYANCE.

    Notwithstanding section 27 of the Merchant Marine Act, 1920 (46 
U.S.C. App. 883), section 8 of the Act of June 19, 1886 (24 Stat. 81, 
chapter 421; 46 U.S.C. App. 289), and sections 12106 and 12108 of title 
46, United States Code, the Secretary of Transportation may issue a 
certificate of documentation with appropriate endorsement for 
employment in the coastwise trade and fisheries for the vessel 
CROYANCE.
                                 <all>
```